Clinicians’ preferences and attitudes towards the use of lithium in the maintenance treatment of bipolar disorders around the world: a survey from the ISBD Lithium task force

被引:0
作者
Diego Hidalgo-Mazzei
Tim Mantingh
Xavier Pérez de Mendiola
Ludovic Samalin
Juan Undurraga
Sergio Strejilevich
Emanuel Severus
Michael Bauer
Ana González-Pinto
Willem A. Nolen
Allan H. Young
Eduard Vieta
机构
[1] University of Barcelona,Bipolar and depressive disorders unit, Department of Psychiatry and Psychology, Hospital Clínic, IDIBAPS
[2] Universitat de Barcelona (UB),Departament de Medicina, Facultat de Medicina i Ciències de la Salut
[3] Instituto de Salud Carlos III,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)
[4] King’s College London,Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience
[5] Research Group on Severe Mental Illness,Bioaraba, Psychiatry Service, Department of Neurosciences
[6] Araba University Hospital,Department of Psychiatry, CHU Clermont
[7] University of the Basque Country UPV/EHU,Ferrand
[8] University of Clermont Auvergne,Department of Neurology and Psychiatry
[9] CNRS,Department of Psychiatry and Psychotherapy
[10] Clermont Auvergne INP,Department of Psychiatry, University Medical Center Groningen
[11] Institut Pascal (UMR 6602),undefined
[12] Clinica Alemana Universidad Del Desarrollo,undefined
[13] Área,undefined
[14] Asistencia e investigación en trastornos del ánimo,undefined
[15] University Hospital Carl Gustav Carus,undefined
[16] TU Dresden,undefined
[17] University of Groningen,undefined
来源
International Journal of Bipolar Disorders | / 11卷
关键词
Lithium; Bipolar disorders; Treatment; Maintenance; Survey; Use; Preferences; Attitudes;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 221 条
[1]  
Andrade LH(2014)Barriers to mental health treatment: results from the WHO World Mental Health surveys Psychol Med 44 1303-17
[2]  
Alonso J(2022)Lithium: What can we do to overcome the discrepancies between evidence, guideline recommendations and clinical practice? Eur Neuropsychopharmacol 60 1-3
[3]  
Mneimneh Z(2020)Drug treatment for patients with bipolar disorders in psychiatric practices in Germany in 2009 and 2018 Psychiatry Res. 289 112965-2
[4]  
Wells JE(2001)Lithium for maintenance treatment of mood disorders Cochrane Database Syst Rev 23 211-67
[5]  
Al-Hamzawi A(2021)The rebirth of lithium as the archetypal mood stabilizer Bipolar Disord 187 559-8
[6]  
Borges G(2005)Cost-effectiveness of clinical interventions for reducing the global burden of bipolar disorder Br J Psychiatry 320 2417-8
[7]  
Bauer M(2018)Addressing health-related misinformation on social media JAMA 9 1-2
[8]  
Bohlken J(2021)Overview of lithium’s use: a nationwide survey Int J Bipolar Disord 12 1687-13
[9]  
Bauer M(2016)A new look at an old drug: neuroprotective effects and therapeutic potentials of lithium salts Neuropsychiatr Dis Treat 54 100-8
[10]  
Kostev K(2022)Lithium treatment of Bipolar disorder in adults: a systematic review of randomized trials and meta-analyses Eur Neuropsychopharmacol 10 1-501